Cigna price target raised to $388 from $384 at Guggenheim

Guggenheim analyst Jason Cassorla raised the firm’s price target on Cigna (CI) to $388 from $384 and keeps a Buy rating on the shares. Favorable EPS upside in the quarter is “partially explained” by the timing of the Medicare sale, but “more importantly” on medical cost trends that showed favorability to expectations, the analyst tells investors. The firm believes the quarter’s performance adds “further justification” for the upside opportunity later this year and into 2026 and beyond, the analyst tells investors.